Suppressor of cytokine signaling-1 inhibits VAV function through protein degradation

被引:150
作者
De Sepulveda, P
Ilangumaran, S
Rottapel, R
机构
[1] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada
[2] Univ Toronto, Dept Med, Toronto, ON M5G 2M9, Canada
[3] Univ Toronto, Dept Immunol & Med Biophys, Toronto, ON M5G 2M9, Canada
关键词
D O I
10.1074/jbc.C000106200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Suppressor of cytokine signaling-1 (SOCS1) is an inducible Src homology 2 (SH2)-containing protein that negatively regulates cytokine and growth factor signaling required during thymic development. Recent evidence indicates that SOCS1 interacts with elongins B and C, which are components of a ubiquitin ligase complex, VCB (VHL/elonginC/B), based on the VHL (von Hippel Lindau) tumor suppressor protein. SOCS1 has previously been shown to operate as an inhibitor of Janus kinases. Here we show that SOCS1 has the distinct function of targeting the hematopoietic specific guanine nucleotide exchange factor, VAV, for ubiquitin-mediated protein degradation. VAV and SOCS1 form a protein complex through interactions between the VAV NH,terminal regulatory region and the SH2 domain of SOCS1 in a phosphotyrosine-independent manner. SOCS1 decreases the steady state levels of cotransfected VAV and onco-VAV and reduces the focus forming activity of onco-VAV. SOCS1 stimulates the polyubiquitination of VAV proteins in vivo, which was stabilized by proteasomal inhibitors. These results suggest that SOCS1 programs VAV degradation by acting as a substrate-specific recognition component of a VCB-like ubiquitin ligase complex.
引用
收藏
页码:14005 / 14008
页数:4
相关论文
共 32 条
[1]   Involvement of NH2-terminal sequences in the negative regulation of Vav signaling and transforming activity [J].
Abe, R ;
Whitehead, IP ;
O'Bryan, JP ;
Der, CJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (43) :30410-30418
[2]   SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine [J].
Alexander, WS ;
Starr, R ;
Fenner, JE ;
Scott, GL ;
Handman, E ;
Sprigg, NS ;
Corbin, JE ;
Cornish, AL ;
Darwiche, R ;
Owczarek, CM ;
Kay, TWH ;
Nicola, NA ;
Hertzog, PJ ;
Metcalf, D ;
Hilton, DJ .
CELL, 1999, 98 (05) :597-608
[3]   Regulatory and signaling properties of the Vav family [J].
Bustelo, XR .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (05) :1461-1477
[4]   Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation [J].
Bustelo, XR ;
Crespo, P ;
LopezBarahona, M ;
Gutkind, JS ;
Barbacid, M .
ONCOGENE, 1997, 15 (21) :2511-2520
[5]  
De Sepulveda P, 1999, EMBO J, V18, P904
[6]   A new protein containing an SH2 domain that inhibits JAK kinases [J].
Endo, TA ;
Masuhara, M ;
Yokouchi, M ;
Suzuki, R ;
Sakamoto, H ;
Mitsui, K ;
Matsumoto, A ;
Tanimura, S ;
Ohtsubo, M ;
Misawa, H ;
Miyazaki, T ;
Leonor, N ;
Taniguchi, T ;
Fujita, T ;
Kanakura, Y ;
Komiya, S ;
Yoshimura, A .
NATURE, 1997, 387 (6636) :921-924
[7]  
Germani A, 1999, MOL CELL BIOL, V19, P3798
[8]   The ubiquitin system [J].
Hershko, A ;
Ciechanover, A .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :425-479
[9]   Twenty proteins containing a C-terminal SOCS box form five structural classes [J].
Hilton, DJ ;
Richardson, RT ;
Alexander, WS ;
Viney, EM ;
Willson, TA ;
Sprigg, NS ;
Starr, R ;
Nicholson, SE ;
Metcalf, D ;
Nicola, NA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (01) :114-119
[10]   Crystal structure of the tyrosine phosphatase SHP-2 [J].
Hof, P ;
Pluskey, S ;
Dhe-Paganon, S ;
Eck, MJ ;
Shoelson, SE .
CELL, 1998, 92 (04) :441-450